WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump Administration’s Final Rule to extend benefits of drug rebates to Medicare beneficiaries:   “Rebates lower drug costs for insurers, but

By Kenneth E. Thorpe President Trump has long promised to lower prescription drug prices. Unfortunately, two of his administration’s newest proposals would actually raise out-of-pocket costs and reduce access to medicines.   They must be scrapped before they do real

The "Most Favored Nations" Executive Order will harm patients by hindering biomedical research   WASHINGTON, D.C. (September 14, 2020) -- Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement in response to

Collaboration, investment and action essential to advancing greater overall health   July 9, 2020 (Washington, D.C.) The Partnership to Fight Infectious Disease (PFID) today released the following statement in response to the International Federation of Pharmaceutical Manufacturers &